Search results
Results from the WOW.Com Content Network
Sinclair (SBGI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Conceived in 2004 by Harvard University biologist David Sinclair and Andrew Perlman, [1] and founded that year by Sinclair and Perlman, along with Christoph Westphal, Richard Aldrich, Richard Pops, and Paul Schimmel, [2] the company was ...
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month.
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. [ 1 ] [ 2 ] Tilray also has operations in Canada, Australia, New Zealand, [ 3 ] [ 4 ] and Latin America, [ 5 ] with growing facilities in Germany and Portugal.
Sinclair said that certain selling stockholders have granted the The company has priced its issue of 18 million class A common shares at $27.25 apiece. Sinclair Broadcast Prices New Stock Issue
Unlike the Sinclair-Tribune deal, opposition to Nexstar's purchase of Tribune was limited, despite the similar broadcast oligopoly concerns raised in the Sinclair acquisition applying to the Nexstar purchase; Nexstar has also tended to focus around local content with the only nationally syndicated news content produced by the group being more ...
Let's see if Sinclair Broadcast Group, Inc. (SBGI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.. Incorporated in 1980 as AntiVirals, [2] shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta ...